Furthermore, the interplay between PON2-mediated redox control, cell proliferation, and apoptosis in therapy-resistant tumours needs exploration to develop synergistic combination treatments that enhance oxidative stress or apoptotic signalling. The gene discussed is PON2; the disease is neoplasm.